儿科与成人患者[¹⁸F]mFBG PET-CT的SUV归一化与参考组织选择
本研究分析35例患者(20例儿科神经母细胞瘤、15例成人嗜铬细胞瘤)共63次[¹⁸F]mFBG PET-CT,比较体重(BW)与瘦体质量(LBM)归一化SUV的变异性及与体重的相关性,并评估肝、血池、骨髓、肌肉作为参考组织的稳定性。结果显示LBM归一化降低SUV变异性,骨髓变异性最低且体重依赖性最小(SUVBW r²=0.45 vs SUVLBMJanma r²=0.31),肝脏SUV最高、血池SUV最低,肌肉可作为弥漫性骨髓摄取时的备选参考组织。
要点
- LBM归一化较BW归一化降低[¹⁸F]mFBG PET-CT的SUV变异性与体重依赖性。
- 骨髓变异性最低、体重依赖性最小(SUVBW r²=0.45 vs SUVLBMJanma r²=0.31)。
- 肝脏SUV最高、血池SUV最低;弥漫性骨髓摄取时肌肉可作备选参考组织。
核心结论
- 基于LBM的SUV归一化降低[¹⁸F]mFBG PET-CT的体重依赖性。
- 骨髓因低变异性和均衡SUV成为最可靠参考组织,弥漫性骨髓摄取时肌肉可作为备选。
- 作者认为这些发现支持标准化LBM校正SUV方法并以骨髓作为主要参考组织以提高诊断准确性。
研究设计与样本
- 分析35例患者的63次[¹⁸F]mFBG PET-CT,其中20例儿科神经母细胞瘤、15例成人嗜铬细胞瘤。
- 在肝、血池、骨髓和肌肉测量SUVmean,分别用体重(SUVBW)、James法LBM(SUVLBMJames)和Janmahasatian法LBM(SUVLBMJanma)归一化。
- 评估SUV变异性及其与体重的相关性。
主要发现
- 基于LBM的归一化较基于BW的归一化降低SUV变异性。
- 骨髓变异性最低且体重依赖性最小:SUVBW的r²=0.45,SUVLBMJanma的r²=0.31。
- 肝脏SUV最高,作为参考组织增加假阴性风险;血池SUV最低,增加假阳性风险。
- 肌肉SUV随体重增加相对稳定,但变异性高于骨髓。
关键数值与推荐
- 骨髓:SUVBW的r²=0.45 vs SUVLBMJanma的r²=0.31。
- 纳入63次[¹⁸F]mFBG PET-CT,来自35例患者(20例儿科神经母细胞瘤、15例成人嗜铬细胞瘤)。
临床怎么用
- 作者认为这些发现支持标准化LBM校正SUV方法并以骨髓作为主要参考组织以提高诊断准确性。
- 作者指出弥漫性骨髓摄取时肌肉可作为备选参考组织。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Meta-[1⁸F]fluorobenzylguanidine ([1⁸F]mFBG) PET-CT is a novel imaging modality for norepinephrine transporter-expressing tumours, such as neuroblastoma and phaeochromocytoma, enabling quantitative assessment and improved diagnostic accuracy compared to meta-[123I]iodobenzylguanidine ([123I]mIBG) scintigraphy. This study aims to: 1) Identify the optimal standardised uptake value (SUV) normalisation method: body weight (BW) or lean body mass (LBM); 2) Determine the most stable reference tissue with SUV uptake below pathological levels. METHODS: We analysed 63 [1⁸F]mFBG PET-CTs from 35 patients (20 paediatric neuroblastoma, 15 adult phaeochromocytoma). SUVmean was measured in the liver, blood pool, bone marrow, and muscle, normalised using BW (SUVBW), LBM via James (SUVLBMJames), and LBM via Janmahasatian (SUVLBMJanma). Variability of SUVs and their correlation with weight were assessed. RESULTS: LBM-based normalisation reduced SUV variability compared to BW-based normalisation. Bone marrow demonstrated the lowest variability and least weight dependency (r2 0.45 for SUVBW versus 0.31 for SUVLBMJanma). The liver had the highest SUVs, increasing the risk of false negatives if used as reference tissue, while the blood pool had the lowest SUVs, raising the risk of false positives. Muscle showed relatively stable SUVs with increasing weight but higher variability than bone marrow. CONCLUSION: LBM-based SUV normalisation reduces weight dependency for [1⁸F]mFBG PET-CT. Bone marrow is the most reliable reference tissue due to its low variability and balanced SUVs, while muscle may serve as an alternative if diffuse bone marrow uptake is present. These findings support standardising LBM-adjusted SUV methods and using bone marrow as the primary reference tissue to enhance diagnostic accuracy. CLINICAL TRIAL REGISTRATION: EudraCT Number: 2019-003713-33; EU Clinical Trials Number: 2024-513622-35-00.
引用
- Samim A, Suurd DPD, van Rooij R, et al. SUV normalisation and reference tissue selection for [1⁸F]mFBG PET-CT in paediatric and adult patients. Eur J Nucl Med Mol Imaging. 2025. PMID: 40172693. doi:10.1007/s00259-025-07242-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。